Human α-fetoprotein binds to primary macrophages

Biochemical and Biophysical Research Communications

Volumn 296, Issue 3, 2002, Pages 507-514

  Atemezem, Aurélie ^a   Mbemba, Elisabeth ^a   Marfaing, Renée ^a   Vaysse, Jenny ^a   Pontet, Michel ^a   Saffar, Line ^a   Charnaux, Nathalie ^a   Gattegno, Liliane ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Fetoprotein; CCR5; Glycans; Macrophages

Indexed keywords

ALPHA FETOPROTEIN; CARBOHYDRATE; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; SIALIDASE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG BINDING SITE; GENETIC TRANSFECTION; HEAT; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ALPHA-FETOPROTEINS; BINDING SITES; BINDING, COMPETITIVE; CELLS, CULTURED; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HUMANS; MACROPHAGES; MONOCYTES; PEPTIDES; RECEPTORS, CCR5;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036382920     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00909-9     Document Type: Article

References (42)

1. B. Mognetti, M. Moussa, J. Croitoru, E. Menu, D. Dormont, P. Roques, G. Chaouat, HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates, Clin. Exp. Immunol. 199 (2000) 486-492.
2. S. H. Lewis, C. Reynolds-Kohler, H.E. Fox, J.A. Nelson, HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses, Lancet 335 (1990) 565-568.
3. A. Coulomb-L'Hermin, A. Amara, C. Schi3, I. Durand-Gasselin, A. Foussat, T. Delaunay, G. Chaouat, F. Capron, N. Ledde, P. Galanaud, F. Arenzana-Seisdedos, D. Emilie, Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells, Proc. Natl. Acad. Sci. USA 98 (1999) 8585-8590.
4. D. R. Klatzmann, J.S. McDouglas, P.J. Maddon, The CD4 molecule and HIV infection, Immunodefic. Rev. 2 (1990) 43-66.
5. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, E.A. Berger, CC CKR-5: A RANTES, MIP-1α, MIP-1β receptor as a function cofactor for macrophage-tropic HIV-1, Science 272 (1996) 1955-1958.
6. A. Amara, S. Le Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J.L. Virelizier, F. Arenzada-Seisdedos, HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication, J. Exp. Med. 186 (1997) 139-146.
7. C.C. Bleul, M. Farzan, H. Chloe, C. Parolin, I. Clark-Lewis, J. Sodroski, T.A. Springer, The lymphocyte chemoattractant SDF-1 is a ligand for CXCR4/fusion and blocks HIV entry, Nature 282 (1996) 829-833.
8. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, N.R. Landau, Identification of a major coreceptor for primary isolates of HIV-1, Nature 381 (1996) 661-666.
9. E. Oberlin, A. Amara, F. Bachelirie, C. Bessia, J.L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.M. Heard, I. Clark-Lewis, D.F. Legler, M. Loetscher, M. Baggiolini, B. Moser, The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell line-adapted HIV-1, Nature 382 (1996) 833-837.
10. R.I. Connor, K.E. Sheridan, D. Ceradini, S. Choe, N.R. Landau, Change in coreceptor use correlates with disease progression in HIV-1 infected individuals, J. Exp. Med. 185 (1997) 625-628.
11. E. Fenouillet, B. Clerget-Raslain, J.C. Gluckman, D. Guétard, L. Montagnier, E. Bahraoui, Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis, J. Exp. Med. 3 (1989) 807-821.
12. E. Fenouillet, J.C. Gluckman, E.M.J. Bahraoui, Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1, J. Virol. 64 (1990) 2841-2848.
13. E. Fenouillet, J.C. Gluckman, I.M. Jones, Functions of HIV envelope glycans, Trends Biochem. Sci. 19 (1994) 65-70.
14. L. Gattegno, B.H. Sadeghi, L. Saffar, D. Bladier, B. Clerget-Raslain, J.C. Gluckman, E. Bahraoui, β-D-N-Acetylglucosaminyl binding properties of the major envelope glycoprotein of human immunodeficiency virus type 1, Carbohydr. Res. 213 (1991) 79-93.
15. M. Haidar, N. Seddiki, J.C. Gluckman, L. Gattegno, Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1, Glycoconj. J. 9 (1992) 315-323.
16. L. Rabehi, F. Ferrìere, L. Gattegno, Specific interaction between HIV-1 major envelope glycoprotein and orosomucoid, Glycoconj. J. 12 (1995) 7-16.
17. N. Seddiki, L. Rabehi, A. Benjouad, L. Saffar, F. Ferriere, J.C. Gluckman, L. Gattegno, E3ect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes, Glycobiology 7 (1997) 1229-1236.
18. M. Haidar, J.C. Gluckman, L. Gattegno, Mannosyl/N-acetyl-β-D-glucosaminyl binding properties of the envelope glycoproteins of human immunodeficiency virus type 2, Glycobiology 2 (1992) 429-435.
19. E.A. Berger, R.W. Doms, E.M. Fenyö, B.T. Korber, D.R. Littman, J.P. Moore, Q.J. Sattentau, H. Schuitemaker, J. Sodroski, R.A. Weiss, A new classification for HIV-1, Nature 391 (1998) 240-244.
20. D. Gitlin, Normal biology of α-fetoprotein, Ann. NY Acad. Sci. 259 (1975) 7-16.
21. G.I. Abelev, α-Fetoprotein: 25 years of study, Tumor. Biol. 10 (1989) 63-74.
22. Y. Koyama, M. Sakai, T. Kitagaawa, K. Taketa, S. Nishi, Lectin affinity electrophoretic demonstration of tissue specificity and malignant alteration of human α-fetoprotein isoforms produced transgenic mice, Biochem. Biophys. Res. Commun. 233 (1996) 757-761.
23. Y. He, B.A. Keel, Biochemical characterization of bovine a-fetoprotein and comparison with human α-fetoprotein, Comp. Biochem. Physiol. Biochem. Mol. Biol. 108 (1994) 327-336.
24. M. Seppala, Increased α-fetoprotein in amniotic fluid associated with congenital oesophagial atresia, Obstet. Gynecol. 42 (1973) 613-624.
25. N. Wald, S. Barker, R. Peto, D.J.H. Brock, J. Bonnar, Maternal serum α-fetoprotein levels in multiple pregnancy, Br. Med. J. 1 (1975) 651-652.
26. N. Seddiki, A. Benyounes-Chennoufi, A. Benjouad, L. Saffar, N. Baumann, J.C. Gluckman, L. Gattegno, Membrane glycolipids and human immunodeficiency virus infection of primary macrophages, AIDS Res. Hum. Retroviruses 12 (1996) 695-703.
27. N. Seddiki, A. Ramdani, L. Saffar, J. Portoukalian, J.C. Gluckman, L. Gattegno, A monoclonal antibody directed to sulfatides inhibits the binding of human immunodeficiency virus (HIV-1) envelope glycoprotein to macrophages but not their infectivity by the virus, Biochem. Biophys. Acta 1225 (1994) 289-296.
28. A. Valentin, A. Von Gegerfelt, S. Matsuda, K. Nilsson, B. Asjö, In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection, J. Acquir. Immune Defic. Syndr. 4 (1991) 751-759.
29. R. Solari, R.E. Offord, S. Remy, J.P. Aubry, T.M.C. Wells, E. Whitehorn, T. Oung, A.E.L. Proodfoot, Receptor-mediated endocytosis of CC-chemokines, J. Biol. Chem. 272 (1997) 9617-9620.
30. L. Rabehi, N. Seddiki, A. Benjouad, J.C. Gluckman, L. Gattegno, Interactions of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages, AIDS Res. Hum. Retroviruses 18 (1998) 1605-1615.
31. K. Schmidt, H. Kaufmann, F. Isemura, J. Emura, T. Motuyama, M. Ishiguro, S. Nanno, Structure of α-1 acid glycoprotein: the complete amino acid sequence, multiple amino acid substitutions and homology with the immunoglobulins, Biochemistry 12 (1973) 2711-2724.
32. K. Schmidt, R.B. Nimberg, A. Kimura, H. Yamaguchi, J.P. Binette, The carbohydrate units of human plasma α-1 acid glycoprotein, Biochim. Biophys. Acta 492 (1977) 291-302.
33. B. Lee, M. Sharron, C. Blanpain, B.J. Doranz, J. Vakili, P. Setoh, E. Berg, G. Liu, H.R. Guy, S.R. Durell, M. Parmentier, C.N. Chang, K. Price, M. Tsang, R.W. Doms, Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function, J. Biol. Chem. 274 (1999) 9617-9626.
34. A.J. Vila-Coro, M. Mellado, A. Martin de Ana, P. Luca, G. del Real, A.C. Martinez, J.M. Rodriguez-Frade, HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization, Proc. Natl. Acad. Sci. USA 97 (2000) 3388-3393.
35. E.C. Brinkman-Van der Linden, E.R. Sjoberg, L.R. Juneja, P.R. Crocker, N. Varki, A. Varki, Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs, J. Biol. Chem. 275 (2000) 8633-8640.
36. A. Olinescu, M. Laky, D.E. Pofescu, A. Dumitrescu, D. Ganea, The effect of α-fetoprotein on the immune response. III. Diminution of the phagocytic capacity of macrophages cultures in vitro in the presence of mouse amniotic fluid or α-fetoprotein, Arch. Roum. athol. Exp. Microbiol. 36 (1978) 247-253.
37. Y. Suzuki, Q.Y. Carl, Y. Zeng, E. Alpert, Isolation and partial characterization of a specific α-fetoprotein receptor on human monocytes, J. Clin. Invest. 90 (1992) 1530-1536.
38. J. Naval, M. Villacampa, A. Guoguel, J. Uriel, Cell-type specific receptors for α-fetoprotein in mouse T-lymphoma cell line, Proc. Natl. Acad. Sci. USA 82 (1985) 3301-3305.
39. 1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages, Biochem. J. 356 (2001) 121-128.
40. S. Azamzi, L. Ylisastigui, Y. Bakri, L. Rabehi, L. Gattegno, M. Parmentier, J.C. Gluckman, A. Benjouad, The inhibitory effect of RANTES on infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on macrophage activation state, Virology 252 (1998) 96-105.
41. S. Ali, A.C. Palmer, B. Banerjee, S.J. Fritchley, J.A. Kirby, Examination of the function of RANTES, MIP-1α, and MIP-1α following interaction with heparin-like glycosaminoglycans, J. Biol. Chem. 275 (2000) 11721-11727.
42. A. Ly, L. Stamatatos, V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies, J. Virol. 74 (2000) 6769-6776.